GENERIC STERILE INJECTABLES MARKET ANALYSIS

Generic Sterile Injectables MarketSize and Trends

Global generic sterile injectables market is estimated to be valued at USD 46.33 Bn in 2024 and is expected to exhibit a CAGR of 10.3% during the forecast period (2024-2031).

Market players are engaged in receiving approvals from the regulatory authorities, in order to expand their product portfolio. This is expected to drive growth of the global generic sterile injectables market over the forecast period.

Increasing inorganic activities such as acquisitions, in order to increase the product portfolio is expected to drive the growth of the global generic sterile injectables market over the forecast period

Market players are focused on inorganic activities such as acquisitions and is expected to drive growth of the global generic sterile injectables market over the forecast period. For instance, in March 2020, Baxter International Inc., expects sales to grow approximately 4% on a compounded annual basis at constant currency rates from 2016 to 2020 by focusing on cost optimization and portfolio management. The company is expected to generate free cash flow of approximately US$ 1.75 Bn in 2020.

Moreover, in 2017, Fresenius Kabi AG, healthcare company, acquired Akorn, Inc., manufacturer of over the- counter pharmaceuticals products, for approximately US$ 4.3 billion. This acquisition represents a potential innovative growth opportunity for its sterile injectables business portfolio.

Market Trends

Figure 1. Global Generic Sterile Injectables Market Value (US$ Bn), by Region, 2024

Market Trends

Figure 2. Global Generic Sterile Injectables Market Share, By Drug Type, 2024